Revolutionize diabetes diagnostics with Diazyme’s comprehensive panel

Diazyme Laboratories presents the Diabetes Panel, a complete solution for monitoring and managing diabetes. Featuring HbA1c with on-board lysis, glycated serum protein (GSP), and 1,5-anhydroglucitol (1,5-AG), this innovative panel delivers unmatched accuracy and diagnostic insights.

Why choose the Diazyme Diabetes Panel?

The Diabetes Panel combines three biomarkers for a comprehensive view of glycemic control:

• HbA1c (on-board lysis): Our HbA1c assay incorporates on-board lysis to simplify testing workflows and improve efficiency. This feature enables labs to directly process whole blood samples without requiring manual pre-treatment, reducing hands-on time and the risk of errors. With faster turnaround and improved accuracy, HbA1c provides reliable reflections of average blood sugar levels over the past 2-3 months.
• GSP: A key marker for short-term glycemic changes, GSP offers insights into blood sugar fluctuations over the preceding 2-3 weeks, helping clinicians adjust treatment plans swiftly and effectively.
• 1,5-AG: This unique marker identifies postprandial glucose spikes, providing critical information on glycemic variability that other tests might overlook.
• The Diazyme Diabetes Panel integrates these critical markers, enabling laboratories to offer comprehensive diabetes diagnostics with ease. Featuring streamlined workflows, exceptional performance, and compatibility with a wide range of chemistry analyzers, the Panel provides the tools labs need to deliver faster and more actionable results. 

Supported by Diazyme’s commitment to innovation and quality, the Diabetes Panel empowers healthcare providers to improve outcomes for patients with diabetes. Experience reliable results, optimized efficiency, and greater diagnostic insight with Diazyme.

Learn more.

Industry Insights articles are created and paid for by advertisers. The views expressed in these articles do not necessarily represent ADLM's views, and their inclusion in CLN is not an endorsement by CLN or ADLM.